ieCrowd is a growing global community of impact investors with a mission to bring breakthrough health innovations to market that bring solutions to global challenges. At ieCrowd, we secure full worldwide rights to commercialize health inventions. Once secured, we form a new subsidiary under ieCrowd for each innovation, and we assign and support in-house teams to focus on developing and bringing the innovations to market. This approach allows us to develop more than one innovation at a time, and diversifies shareholder risk amongst our subsidiaries. Our experienced team has a track record of successfully bringing innovations to market, but we realized that together, as a crowd, we can have a larger impact on world health by commercializing more innovations and spreading our investors' risk among those innovations. By partnering with leading research institutions and universities, we have access to a pipeline of innovations that usually don't make it out of the lab, but have the potential to improve health on a global scale. Our team of entrepreneurs, scientists, engineers, and impact investors identify and license the innovations that we believe will provide the highest financial return and will have the largest impact on global health. To further mitigate investor risk, the technologies we license and commercialize must have received prior funding from public or private sources to finance the discovery’s research and development before we license the innovations and bring them to market. Please follow us to hear about news, jobs and other opportunities.